Call Options

7 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2024

May 15, 2024

SELL
$322.13 - $400.59 $15.8 Million - $19.6 Million
-49,000 Reduced 10.53%
416,500 $166 Million
Q4 2023

Feb 14, 2024

BUY
$258.49 - $338.39 $37.5 Million - $49 Million
144,900 Added 45.2%
465,500 $157 Million
Q3 2023

Nov 14, 2023

BUY
$284.35 - $354.93 $9.78 Million - $12.2 Million
34,400 Added 12.02%
320,600 $93.7 Million
Q2 2023

Aug 14, 2023

SELL
$253.53 - $341.94 $21.9 Million - $29.5 Million
-86,400 Reduced 23.19%
286,200 $97.9 Million
Q1 2023

May 15, 2023

SELL
$224.75 - $271.36 $130 Million - $157 Million
-578,800 Reduced 60.84%
372,600 $95.2 Million
Q4 2022

Feb 14, 2023

SELL
$183.06 - $281.74 $20.4 Million - $31.4 Million
-111,600 Reduced 10.5%
951,400 $252 Million
Q3 2022

Nov 14, 2022

SELL
$186.38 - $242.46 $49.4 Million - $64.3 Million
-265,300 Reduced 19.97%
1,063,000 $199 Million

Others Institutions Holding ISRG

About INTUITIVE SURGICAL INC


  • Ticker ISRG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 353,384,992
  • Market Cap $157B
  • Description
  • Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endo...
More about ISRG
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.